any bacteria retain the ability to switch into a walldeficient state called the L-form 1 , which is completely resistant to antibiotics that work specifically on cell wall synthesis, including β-lactams. L-forms have been identified as antibiotic resistant organisms in samples from humans and thus they may contribute to chronic or recurrent infections [2] [3] [4] . In both a free-living Bacillus subtilis and a pathogenic Staphylococcus aureus, host lytic enzymes (especially lysozyme) can promote an L-form switch that enables the organism to evade β-lactam action and continue proliferating 5 . B. subtilis has been used as a tractable model system for studying the molecular biology of L-forms 4, 6 . Inhibition of de novo peptidoglycan (PG) synthesis traps the membrane-bound L-form inside the original PG wall. Autolytic enzymes or exogenous PG hydrolases, such as lysozyme, can degrade the wall, enabling the L-form to escape and survive in isotonic environments 5, 7 ( Supplementary Fig. 1a ). L-form proliferation seems to involve a simple biophysical effect based on an increased rate of surface area synthesis compared to volume synthesis, driving cell shape deformations that lead to spontaneous scission 8 . However, because reactive oxygen species (ROS) originating from the respiratory chain (RC) pathway are abnormally increased in cell-wall-deficient cells, the reduction of RC activity or high levels of ROS scavengers are normally required to support robust L-form growth 9 ( Supplementary Fig. 1a ). L-form growth of the Gram-negative bacterium Escherichia coli was also stimulated under anaerobic conditions or by adding a ROS scavenger, suggesting that oxidative damage might be an important impediment to L-form growth in a wide range of bacteria [9] [10] [11] . Nevertheless, it remained unclear why the L-form transition should result in increased ROS.
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ROS are generated as a natural side effect of cellular metabolism and aerobic respiration. The PG wall synthesis pathway is one of the major drains on carbon in the central metabolic pathway (Fig. 1a) , so we favour a model in which blocking PG synthesis results in the rerouting of phospho-sugars towards catabolic rather than anabolic pathways. This could, in turn, result in stimulated flux into the tricarboxylic acid (TCA) cycle, leading to the increased generation of ROS as a by-product of the metabolism of molecular oxygen in the RC pathway.
Here we show that the abnormal generation of ROS in the L-form transition correlates with an increase in glycolytic activity in B. subtilis and probably other Gram-positive bacteria, including pathogens. Moreover, we show that a reduction in glycolytic activity or the activation of gluconeogenesis (which acts as the reverse of glycolysis) can compensate for the metabolic imbalance, reducing the oxidative damage and thus promoting L-form growth, thereby evading β-lactam killing. Consistent with this model, glycolysismediated killing did not occur during the L-form transition in the pathogen Enterococcus faecium, which lacks the RC pathway 12, 13 . Our results show how a specific metabolic diversion induced by β-lactam antibiotics contributes to cell killing in Gram-positive bacteria and provide an understanding of the conditions that influence the ability of cells to grow in the L-form state. an efficient L-form switch when the cells have an ispA mutation (or other mutations that affect the RC pathway) but not in ispA + cells 6, 8 . The ispA product is thought to contribute to the synthesis of menaquinone, an electron carrier in the RC pathway 9, 14 ( Fig. 1a) . To test whether the requirement for the ispA mutation was due to glycolytic activity, we put the gapA gene, which encodes glyceraldehyde 3-phosphate dehydrogenase (an essential component of the glycolytic pathway 15 ; Fig. 1a B. subtilis strains BS115 (P xyl -murE ispA + ) and LR2 (P xyl -murE ispA − ) were streaked on NA + magnesium−sucrose−maleic acid (MSM) (sucrose) plates, with (MurE ON) or without (MurE OFF) 1% xylose, and incubated at 30 °C (left and middle). Phase contrast micrographs of LR2 (right) were taken from the plates with (MurE ON) or without (MurE OFF) xylose (middle). c, The effects of the repression of gapA on cell growth in the walled and L-form states. B. subtilis strain YK1621 (P xyl -murE P spacHY -gapA) was streaked on NA + MSM (sucrose) plates, with (GapA ON) or without (GapA OFF) 1 mM isopropyl-β-d-thiogalactoside (IPTG), in the presence (MurE ON) or absence (MurE OFF) of 1% xylose, and incubated at 30 °C. Phase contrast micrographs of YK1621 (right) were taken from the plates without IPTG (GapA OFF) and in the presence (MurE ON) or absence (MurE OFF) of xylose (middle). Scale bars in b,c (right), 3 μm. d, A schematic representation of the UDP-GlcNAc pathway in B. subtilis. e, The effects of the repression of glmM on L-form growth. B. subtilis strains YK1563 (P xyl -murE ispA − P spac -glmM), YK1763 (YK1563 ndh − ), YK1764 (YK1563 qoxB − ), YK1765 (YK1563 ctaB − ) and YK1995 (YK1563 mhqR − ) were streaked on NA + MSM plates with (GlmM ON) or without (GlmM OFF) 1 mM IPTG in the absence of xylose (MurE OFF) and incubated at 30 °C. The figures are representative of at least three independent experiments (b,c,e). UDP-GlcNAc, uridine 5′-diphospho-N-acetylglucosamine. NADH, reduced nicotinamide adenine dinucleotide. FADH 2 , reduced flavin adenine dinucleotide.
Results

Repression of glycolytic activity promotes L-form growth.
that glycolysis is required for the efficient growth of the walled cells under these culture conditions. When the precursor pathway was blocked (MurE OFF), no L-form growth was observed in the presence of IPTG ( Fig. 1c ; MurE OFF + GapA ON). However, growth did occur in the absence of IPTG and phase contrast microscopy showed the presence of heterogenous spheroidal L-forms on the plates ( Fig. 1c ; MurE OFF + GapA OFF), similar to those of the ispA − strain (Fig. 1b) . Thus, reduction of glycolytic activity can substitute for ispA mutation in promoting L-form growth.
Metabolic rerouting prevents L-form growth. UDP-GlcNAc, an essential precursor of lipid II, is generated from fructose-6-phosphate (a glycolytic intermediate; Fig. 1a ) through the action of the glmS, glmM and gcaD gene products (Fig. 1d) . The glmS riboswitch is a ribozyme that self-cleaves after binding glucosamine-6-phosphate, the product of the enzyme encoded by glmS (ref. 16 ; Fig. 1d ). We expected that blockage of the UDP-GlcNAc pathway by repressing glmM, and indirectly also glmS, should result in the rerouting of glucose metabolism towards glycolysis. To test the effects of this metabolic switch on L-form growth, we put the glmM gene under IPTG control in the LR2 strain (P xyl -murE ispA − ). In the presence of IPTG (GlmM ON) but no xylose (MurE OFF), efficient L-form growth was observed (Fig. 1e , left, control). However, growth did not occur when the expression of glmM was repressed (Fig. 1e , right, control). If the growth defect was caused by increased ROS production from the RC pathway through increased glycolytic activity, it should be suppressed by reducing RC activity. As shown in Fig. 1a , ndh, qoxB and ctaB gene products are involved in the RC system: ndh encodes a major NADH dehydrogenease 17 ; qoxB encodes cytochrome aa 3 quinol oxidase subunit I
18
; and ctaB encodes haem O synthase 19 . We examined the effects of mutations in these genes on L-form growth with glmM repression and found that they all rescued the growth defect (Fig. 1e) . Similar results were obtained by introducing a mutation in mhqR (Fig. 1e) , which encodes a transcriptional repressor for genes induced by the thiol-specific oxidative and/or electrophile stress response 20 (Fig. 1a) . Thus, carbon flux through glycolysis seems to be a serious impediment to L-form growth and it can be bypassed by either downregulating RC activity or upregulating oxidative stress response genes.
Inhibition of the sugar uptake system promotes L-form growth. Sucrose is a disaccharide sugar consisting of glucose and fructose that has frequently been used in L-form culture media to provide an isotonic environment. Many bacteria, including B. subtilis, take up sucrose by the phosphotransferase system (PTS) and consume this through glycolysis to provide cellular energy 21 . In B. subtilis, levansucrase and endolevanase can cleave sucrose externally to glucose and fructose 22 , which are then also utilized via the PTS pathway and glycolysis. According to our model, limiting the uptake of those glycolytic sugars should promote L-form growth by reducing glycolytic flux in the MurE OFF background. The PTS consists of two general components, enzyme I (EI) and phosphocarrier protein (HPr), and a suite of sugar-specific transporters (EII) 23 . We constructed mutants for the sucrose (ΔsacP), glucose (ΔptsG) and fructose (ΔfruA and ΔlevD) transporters, respectively, and an IPTG-inducible mutant for the coregulated universal EI and Hpr proteins (P spac -ptsH−ptsI operon) in the P xyl -murE background. In the walled state (MurE ON), all of the strains grew well, except the ptsHI mutant, which showed slightly slower growth on NA + sucrose plates ( Fig. 2a and Supplementary Fig. 2a ), suggesting that not only sucrose but also other sugars in the plate were used as carbon sources under these conditions. When PG synthesis was blocked (MurE OFF), none of the single deletion mutants showed significant growth (Fig. 2a , middle and right). However, the ptsHI mutant showed efficient L-form growth (Fig. 2b) when repressed (Fig. 2a, middle) but not when induced (Fig. 2a, right) . Thus, inhibition of glycolytic sugar uptake by repressing the PTS system promotes L-form growth without the need for the ispA mutation, probably by reducing glycolytic flux.
As the PTS is also crucial for the signal-transduction pathways in carbon catabolite repression 23 , we tested the effects of deleting ccpA, which encodes a key transcriptional factor in carbon catabolite repression, but no significant stimulation of L-form growth was observed ( Supplementary Fig. 2a ).
Contrasting effects of gluconeogenic carbon sources on L-form growth. Figure 2c ,d shows that glucose (NA + 0.5 M glucose), which is a highly favoured glycolytic carbon source in many bacteria, could substitute for sucrose in providing osmotic support for B. subtilis L-form growth, but again this required a mutation such as ispA. These findings were largely independent of the growth medium because similar results were obtained when the cells were cultured on minimal medium containing 0.5 M sucrose or glucose as the sole carbon source ( Supplementary Fig. 2b,c) . Again, L-form growth was readily observed in the ispA mutant, but not in the ispA + background, confirming that the reduction of RC activity by the ispA mutation is crucial for B. subtilis L-form growth under glycolytic conditions.
Gluconeogenesis is a metabolic pathway that results in the generation of glucose from certain non-carbohydrate carbon substrates, including malate and succinate, and the reactions are comparable to the reverse of glycolysis. Imported malate enters the TCA cycle, but only 10% is respired via the TCA cycle in B. subtilis 24 . The majority is converted to phosphoenolpyruvate and pyruvate, resulting in an increased gluconeogenic flux and overflow metabolism. Similarly, it has been shown that flux through the TCA cycle is also reduced in the presence of succinate 25 . To test whether increased flux through gluconeogenesis (and/or overflow metabolism) could counteract the inhibitory effect of glycolysis on L-form growth, we streaked P xyl -murE strains with or without an ispA mutation on NA plates containing 0.5 M malate or succinate: L-form growth occurred efficiently even without the ispA mutation (Fig. 2c,d ). Similar results were obtained on minimal medium plates ( Supplementary  Fig. 2b,c) . Thus, a reduction of RC activity by the ispA mutation is not required for L-form growth under gluconeogenic conditions. L-form growth does not require mutational changes under gluconeogenic conditions. β-lactams, including penicillin G (PenG), remain widely used antibiotics that target the penicillin-binding proteins that assemble the PG wall 26 . We recently discovered that innate immune PG hydrolases, such as lysozyme, can rescue various Gram-positive bacteria from β-lactam killing by converting them to L-forms 5 . Supplementary Figs. 1b−e and 2d show that the promotion of L-form growth by combined treatment with PenG and lysozyme (in murE + cells) still required an ispA mutation or other mutations in genes acting on the RC pathway under aerobic glycolytic conditions. However, under gluconeogenic conditions, a completely wild-type (that is murE
subtilis strain could be switched into the L-form state by PenG and lysozyme. As shown in Fig. 3a , the presence of PenG blocked B. subtilis growth on NA + succinate plates (because the L-form protoplast remains trapped inside the cell 5 ), but a lawn of small colonies was readily detectable on plates containing both PenG and lysozyme after 2 d of incubation (because the lysozyme enables the protoplast to escape from the cell and initiate L-form growth 5 ). Phase contrast microscopy of the smaller colonies showed the presence of heterogenous spheroidal L-forms ( Fig. 3b(ii) ). The longer incubation also promoted the emergence of several larger colonies on plates ( Fig. 3a(i) ) that appeared to contain walled cells with typical rod-shaped morphology ( Fig. 3b(i) ). These presumably arose by reversion from L-forms when the antibiotic selection decayed, as described previously 5, 27 . Similar results were observed on succinate plates containing a cephalosporin β-lactam, cephalexin, except that fewer revertant colonies were evident ( Supplementary Fig. 2e ). Thus, under gluconeogenic conditions in the presence of lysozyme, wild-type B. subtilis cells can escape from β-lactam killing by switching to an L-form state without the need for any mutational change.
Time-lapse microscopy was used to view the L-form switch in a wild-type strain. Under glycolytic conditions in the presence of PenG, the addition of lysozyme promoted the emergence of L-forms within 30 min, but they did not grow and frequently lysed ( Fig. 3c and Supplementary Video 1). Although we occasionally observed successful L-form growth (Fig. 3c , red arrows), they eventually lysed (red asterisk at 500 min). In contrast, under gluconeogenic conditions, L-forms emerged from the walled cells and propagated in a typical manner ( Fig. 3d and Supplementary Video 1).
To test whether the failure of L-form growth under glycolytic conditions was due to oxidative damage, we took advantage of a fluorescent fatty acid analogue, C 11 -BODYPY 581/591 , which has been used as an indicator of oxidative damage to lipids 9, 28 . The probe is incorporated into membranes, and the fluorescent properties shift from red to green after free radical-induced oxidation. In wild-type B. subtilis walled cells growing exponentially in NB + glucose medium, the cells exhibited a regular and smooth red fluorescence at the cell surface, but no clear green fluorescence was detectable (Fig. 3e, no  addition) . In contrast, green fluorescence was readily detectable in cells treated with PenG and lysozyme (Fig. 3e , PenG + L), suggesting oxidative damage to lipids in L-forms under glycolytic conditions. Such a fluorescent shift was not observed in L-forms cultured under gluconeogenic conditions (Fig. 3f) .
Increased carbon flux through glycolysis generates ROS toxicity.
The above results suggest that the generation of L-forms from walled cells and/or L-form growth causes a perturbation in the cellular metabolism under glycolytic conditions, leading to ROSmediated cell death (Supplementary Fig. 3a) . To test this, we carried Although no significant changes occurred in the pool size of intracellular pyruvate (Fig. 4a) , we observed increased extracellular pyruvate in the presence of PenG and lysozyme (Fig. 4b) . This finding provided direct support for the idea that flux through glycolysis is increased during L-form growth.
Bacillithiol plays an important role in the detoxification of ROS 30 and the promotion of L-form growth under aerobic glycolytic conditions ( Supplementary Fig. 3b −d) 9 . We analysed the samples used for the above experiments and found that intracellular bacillithiol levels were significantly reduced in the wild-type cells treated with PenG and lysozyme ( Fig. 4c and Supplementary Fig. 4 ), suggesting that bacillithiol is consumed due to the accumulation of ROS. However, the reduction did not occur in the ispA mutant cells (Fig. 4 and Supplementary Fig. 4 ), again consistent with the idea that increased flux through glycolysis due to the inhibition of PG synthesis causes increased ROS generation from the RC pathway, leading to cell death.
Gluconeogenic growth protects S. aureus and Listeria monocytogenes from β-lactam killing. We examined whether these observations also held for a pathogenic Gram-positive bacterium, S. aureus. Here, we replaced lysozyme with lysostaphin, a more effective hydrolytic enzyme for S. aureus PG (ref. 31 ). As shown in Fig. 5a,b and others have reported that S. aureus L-form growth does occur on complex rich medium containing sucrose as an osmoprotectant 5, 27, 32, 33 , L-form growth requires the uptake and metabolism of glycerol, which is a substrate for gluconeogenesis 32 , suggesting that sucrose may not be the primary carbon source under those conditions. PenG prevents PG assembly and is generally thought to induce explosive cell lysis under classical microbiological culture conditions, which are mainly hypotonic. Under osmoprotective conditions, explosive death is largely suppressed but bacteria still die 5 by mechanisms that have not yet been resolved. Given the above Pre. Pre.
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results, we considered whether gluconeogenic growth could also protect walled cells from PenG killing in an isotonic medium. We cultured S. aureus walled cells in NB containing 0.5 M glucose or succinate. The growth arrest was induced in both cultures shortly after the addition of PenG (Fig. 5c, left) . Although no significant changes in optical density (OD) occurred in the succinate culture following PenG treatment, prolonged incubation of the glucose culture resulted in a severe decrease in OD. In parallel with this, the colony forming units (CFU) of the glucose culture decreased over time in the presence of PenG and dropped at least 1,000-fold after overnight incubation (Fig. 5e,f and Supplementary Table 2 ). By contrast, in the succinate culture the CFU fell no more than tenfold after overnight incubation with PenG (Fig. 5e ,f and Supplementary Table 2 ). It thus seems that the efficiency of PenG killing in walled cells is greatly reduced under gluconeogenic conditions. This suggests that oxidative damage through glycolysis contributes greatly to PenG killing in walled S. aureus.
Consistent with a key role for lysozyme in the switch to L-form growth following β-lactam treatment, the OD of the succinate culture was significantly increased by combined treatment with PenG and lysostaphin (Fig. 5c (right), d) . However, in the glucose culture, rapid cell death occurred (Fig. 5c, right) . We do not fully understand the mechanism of the rapid death, but glycolysis-mediated killing via oxidative damage or other mechanisms, such as the futile cycling of PG synthesis and turnover as occurs in E. coli (ref. 34 ), might be enhanced by stripping the PG wall. Nevertheless, those killing effects are largely counteracted under gluconeogenic conditions, leading to robust L-form growth that can evade β-lactam action.
We then examined another pathogenic Firmicute, L. monocytogenes, that is naturally resistant to lysozyme due to N-deacetylation or O-acetylation on the PG wall; elimination of the PG modification by use of a ΔpgdA ΔoatA double mutant results in sensitivity to lysozyme 35, 36 . As shown in Fig. 6a,b , the formation and significant growth of L. monocytogenes L-forms did not occur on glucose plates containing PenG and lysozyme. In contrast, L-form colonies appeared on succinate plates after 2 d, showing that L. monocytogenes behaves similarly to B. subtilis and S. aureus with regard to the effects of glycolytic versus gluconeogenic substrates. Furthermore, L-form growth was much more abundant for the ΔpgdA ΔoatA double mutant than for the wild type (Fig. 6a , succinate, PenG + L), providing further evidence for the importance of cell wall degradation in L-form switching and protection from β-lactam killing 5 .
Lack of RC pathway allows escape from glycolysis-mediated β-lactam killing. Finally, we examined E. faecium, which is also a pathogenic Firmicute but strictly fermentative and completely lacking the RC pathway 12, 13 . Significant E. faecium L-form growth was seen not only on succinate plates but also on glucose plates containing PenG and lysozyme within 2 d of incubation (Fig. 6c) . Presumably, the lack of the RC pathway enables E. faecium to escape from β-lactam killing by switching to the L-form state even under glycolytic conditions. Discussion β-lactam antibiotics inhibit bacterial cell wall assembly and it is generally assumed that the main killing effect arises from loss of cell wall integrity, leading to explosive lysis. However, this kind of lysis does not seem to generally occur for many Gram-positive bacteria, even under non-osmoprotective (hypotonic) conditions; the bacteria are still prevented from growing and die by other mechanisms 5, 37 . Kohanski et al. have proposed a crucial role for ROS 38 (which are generated as a natural side effect of aerobic respiration) in the antibiotic-mediated killing of bacteria, including that arising from β-lactam treatment. However, the extent to which this is responsible for cell killing remains controversial 39, 40 . Nevertheless, recent studies that reveal an important role for cellular metabolism in β-lactam killing further support the involvement of ROS as a metabolic by-product [41] [42] [43] . Our results provide a possible mechanism for this effect. We show that blocking the cell wall pathway stimulates glycolytic flux, leading to ROS production via aerobic respiration (Fig. 1a) . It is not surprising that the inhibition of cell wall synthesis results in dramatic changes in cell physiology because wall synthesis is a major drain on cellular resources, especially in Gram-positive bacteria where the wall comprises 10-20% of the total cell mass. Our results show that physiological compensation for the metabolic imbalance, by reducing glycolytic activity or activating gluconeogenesis, moderates β-lactam toxicity, leading to the proliferation of wall-free L-form bacteria in the presence of lysozyme. The persistent growth of E. faecium (which naturally lacks a RC 12, 13 ) during β-lactam treatment under glycolytic conditions provides strong support for this view (Fig. 6c) . The physiological effects that we have uncovered, especially the sensitivity of cells to intrinsically produced ROS, will be important for efforts to engineer simplified or artificial cells. This work suggests that the use of aerobic respiration comes at a potentially serious cost and that in many organisms cellular metabolism is finely balanced to provide maximum energetic benefit. Perturbations of key central pathways or, in the future, the incorrect design of metabolic pathways may have seriously damaging consequences for the cell.
In many diverse bacteria, the L-form state can be induced experimentally by the treatment of cells with antibiotics and/or lytic enzymes that inhibit cell wall synthesis [2] [3] [4] [5] . A variety of protocols for generating L-forms to specific lineages have been described through decades of research and those culture methods often involve anaerobic conditions 10, 44 , consistent with a role for oxygen toxicity in L-form generation. Our genetic experiments have provided some clarity regarding the physiological changes responsible for this effect; thus, inhibition of the uptake of glycolytic sugars, reduction of glycolytic activity or reduction of RC activity can all promote L-form growth under aerobic glycolytic conditions. It seems likely that the utilization of sugar-phosphate intermediates through glycolysis results in an increased generation of ROS from the RC pathway, which then prevents L-form growth. Stimulation of L-form growth by gluconeogenic growth or oxygen depletion, without the need for any mutational changes, provides further support for this view ( Fig. 3 and Supplementary Fig. 3 ).
As blocking cell wall synthesis eliminates the wall, its precursors and turnover products, which could normally act as ROS scavengers, it is formally possible that the loss of these molecules increases sensitivity to normal levels of ROS. However, we do not favour this idea because cells treated with β-lactam but no lysozyme, which therefore still possess both the wall and precursors, nevertheless suffer from ROS toxicity 38 . Also, the growth of L-forms that lack a wall and in which precursor synthesis is blocked is strongly influenced by modulation of the glycolytic pathway (Fig. 1) . It remains to be determined how the increased flux through glycolysis affects the RC pathway thereby impacting on L-form growth.
Our results also reveal that the avoidance of β-lactam killing by switching to the L-form state depends on two key factors: escape from the cell wall sacculus-which can be effected by exogenous lytic enzymes; and the avoidance of ROS toxicity-which, via reduced glycolytic flux, is suppressed by growth on gluconeogenic carbon substrates (or the lack of an RC). These findings show that the L-form transition can be supported, for a wide range of bacteria, perhaps including both free-living and pathogenic organisms, by conditions found in the natural environment. Indeed, historically, L-form isolation has been reported from a wide range of sites including animal, human and plant hosts, as well as the natural environment [2] [3] [4] [5] . Although the possible role of L-forms in infectious diseases is unclear, β-lactam treatment could effectively facilitate L-form generation in certain niches within the human body because immune PG hydrolases and gluconeogenic substrates, such as lactate, glycerol and amino acids, are abundantly present. Finally, many antibiotics, including penicillin, work by attacking the bacterial cell wall. Our understanding of the physiological changes that are generated by the inhibition of cell wall synthesis, together with their implications for L-form generation and survival, should prompt renewed interest in the possible role of L-forms in persistent or recurrent infections.
Methods
Bacterial strains and growth conditions. The bacterial strains in this study are listed in Supplementary Table 3 . NB (Oxoid) and NA (Oxoid) were used for bacterial growth at 30 °C. Bacterial L-forms were induced and grown on osmoprotective medium composed of 2× MSM pH7 (40 mM magnesium chloride, 1 M sucrose and 40 mM maleic acid) mixed 1:1 with 2× NA, or 2× minimal medium 45 (0.4% ammonium sulphate, 2.8% dipotassium phosphate, 1.2% potassium dihydrogen phosphate, 0.2% sodium citrate dehydrate, 0.04% magnesium sulphate) supplemented with 20 µg ml −1 tryptophan, 0.1% yeast extract, 1 µg ml −1 ferric ammonium citrate, 0.1% glutamic acid, 0.02% casamino acids and 1% agar. 1 M sucrose in 2× MSM was replaced by 1 M glucose, malate or succinate as necessary. 1 mM IPTG or 1% xylose were added to media when required, and antibiotics were also added at the following concentrations: 1 µg ml −1 erythromycin, 200 µg ml −1 PenG, 100 µg ml −1 cephalexin, 100 µg ml
lysozyme and/or 10 µg ml −1 lysostaphin. 1 µg ml −1 8J (FtsZ inhibitor) 46 was used to prevent the growth of walled cells when required 8 . Anaerobic growth conditions were maintained using anaerobic atmosphere generation bags (AnaeroGen, Oxoid) in an anaerobic jar for growth on plates. 10 mM nitrate and 0.1% glutamic acid were added for B. subtilis growth under anaerobic conditions. For growth curve and time course CFU measurement, overnight cell cultures in NB were diluted at 10 -2 in fresh NB + glucose or succinate and incubated at 30 °C with shaking for several hours and the exponential cell cultures (OD 600 nm of about 0.1) were prepared for the experiments. The exponential cell cultures were incubated at 30 °C without shaking.
Construction of an IPTG-inducible gapA gene, ptsHI operon and glmM gene. To construct the IPTG-inducible gapA mutant, the first 200-300 base pairs (bp) of the gapA gene (containing the Shine−Dalgarno sequence) were amplified by PCR from genomic DNA of the B. subtilis strain 168CA using the primers pM4SD− gapA−F and pM4−gapA−R (Supplementary Table 2 ). The amplification product was then cloned between the EcoRI and BamHI sites of the plasmid pMutin4 (ref. 47 ), creating pM4−P spac -gapA. The resulting plasmid was introduced into the strain BS115 to generate YK1571 (Supplementary Table 2 ). In this strain, the fulllength gapA gene is expressed from the IPTG-inducible promoter P spac , but the growth was slower than the parental strain in the presence of IPTG, suggesting insufficient gapA expression to compensate for the native levels of GapA. We therefore introduced a second copy of the P spacHY -gapA fusion into the strain YK1571. The gapA gene containing the Shine-Dalgarno sequence was amplified by PCR from the genomic DNA of B. subtilis strain 168CA, then cloned between the XbaI and SphI sites of plasmid pPL82 (ref. 48 ), creating pPL82-gapA. The resulting plasmid was used to generate YK1621 in which the full-length gapA are expressed from the IPTG-inducible promoter P spacHY at the amyE locus on the chromosome (Supplementary Table 2) .
To construct the IPTG-inducible ptsHI mutant, the first 200~300 bp of the ptsH gene (containing the Shine−Dalgarno sequence) were amplified by PCR from the genomic DNA of the B. subtilis strain 168CA using the primers pM4SD−ptsHI−F and pM4−ptsHI−R (Supplementary Table 2 ). The amplification product was then cloned between the EcoRI and BamHI sites of the plasmid pMutin4 (ref. 47 ), creating pM4−P spac -ptsHI. The resulting plasmid was introduced into the strain BS115 to generate YK1601 (Supplementary Table 2 ). In this strain, the full-length ptsHI operon is expressed from the IPTG-inducible promoter P spac .
To construct the IPTG-inducible glmM mutant, the first 200~300 bp of the glmM gene (containing the Shine−Dalgarno sequence) were amplified by PCR from genomic DNA of the B. subtilis strain 168CA using the primers pM4SD−glmM−F and pM4−glmM−R (Supplementary Table 2 ). The amplification product was then cloned between the EcoRI and BamHI sites of plasmid pMutin4 (ref. 47 ), creating pM4−P spac -glmM. The resulting plasmid was introduced into the strain LR2 to generate YK1563 (Supplementary Table 2 ). In this strain, the full-length glmM is expressed from the IPTG-inducible promoter P spac . DNA manipulations and transformations were carried out using standard methods.
Construction of disruption mutants.
To construct the ptsG, sacP, fruA and levD disruption mutant, internal segments of those genes were amplified by PCR from B. subtilis strain 168CA genomic DNA using the primers listed in Supplementary Table 2. The amplification products were then cloned between the EcoRI and BamHI sites of plasmid pMutin4 (ref. 47 ), creating pMutin4−ptsG, sacP, fruA and levD. The resulting plasmids were introduced into the strain BS115 to generate disruption mutants (Supplementary Table 2 ). DNA manipulations and transformations were carried out using standard methods.
Microscopic imaging.
For snapshot live-cell imaging, cells were mounted on microscope slides covered with a thin film of 1% agarose in water, or NB + MSM for L-forms. Images were acquired with a Sony Cool-Snap HQ2 cooled CCD camera (Roper Scientific) attached to a Zeiss Axiovert 200M or Rolera EM-C2 (Q-imaging) camera attached to a Nikon TiE microscope and analysed using Metamorph (Molecular Devices). For the time-lapse imaging, 300 μl of exponentially growing B. subtilis walled cells in NB + glucose or succinate media were placed on 35 mm sterile glass bottom microwell dishes (ibidi GmbH), which were precoated with 2 mg ml −1 BSA and incubated for 5 min. The dishes were centrifuged at 100g for 2 min using a Beckman Allegra X-12R centrifuge. Nonadherent cells were removed, and then a thin layer of NB + glucose with 0.2% agar bacteriological (Oxoid), 100 µg ml −1 PenG and lysozyme was placed on the top of the dishes. The dishes were placed on the microscope stage at 30 °C. Images were acquired with a Sony Cool-Snap HQ2 cooled CCD camera (Roper Scientific) attached to a Zeiss Axiovert 200M and analysed using Metamorph (Molecular Devices). Pictures and videos were prepared for publication using ImageJ (https://imagej.nih.gov/ij) and Adobe Photoshop. ; Life Technologies) as described previously 9 . Exponentially growing B. subtilis walled cells were cultured in NB + glucose or succinate media at 37 °C and then 5 μM C 11 -BODIPY 581/591 was added to the culture and incubated for 1 h at 30 °C before being used for microscopic analysis. For L-forms, 100 µg ml −1 PenG and lysozyme were added to the cultures with exponentially growing B. subtilis walled cells and incubated for 1 h at 37 °C. The cultures were further incubated for several hours at 30 °C without shaking and then 5 μM C 11 -BODIPY 581/591 was added to the culture.
Metabolome analysis.
For the metabolome analysis, NB (Difco) supplemented with 5 g l −1 NaCl and 0.4 M glucose (NBG) was used. The NBG was supplemented with 15 g l −1 agar (NAG) to generate solid plates. For the intracellular metabolome analysis, B. subtilis cells were grown in NBG until the mid-log phase; 10 8 cells were collected on 0.22 µm filters and then transferred into NAG and incubated overnight at 30 °C to allow replication and biomass production. Then, the cell-laden filters were used as an unlabelled preculture control or placed in fresh NAG plates containing 20% U- 13 C-glucose (Sigma-Aldrich), with or without 200 µg ml −1 PenG and lysozyme, and incubated at 30 °C. The cells were collected at 0 (preculture control), 45, 90 and 120 min and polar metabolites were extracted in prechilled (−40 °C) methanol:acetonitrile: water solution as previously described 49 . For the exometabolome analysis, B. subtilis cultures were grown in NBG until the mid-log phase and the culture filtrates were collected by 0.2 µm filters as an unlabelled preculture control. Next, 10 8 cells were collected from the log phase cultures and resuspended in a fresh 4 ml of NBG containing 20% U- Liquid chromatography−mass spectrometry was performed using a modified protocol described previously 50 . Briefly, aqueous normal phase liquid chromatography was performed using an Agilent 1200 LC system at controlled temperature (4 °C). A flow rate of 0.4 ml min −1 was used. Elution of polar metabolites was performed using a gradient of two solvents: A (mQ water and 0.1% formic acid) and B (acetonitrile and 0.1% formic acid). Accurate-mass spectrometry was performed using an Agilent Accurate Mass 6230 time of flight apparatus equipped with a Dual Agilent Jet Stream electrospray ionization source. The data were analysed using Profinder B.08.00 and Mass Hunter Qualitative Analysis B.07.00 (Agilent). The metabolites were identified by comparing the accurate m/z (error < 10 ppm) and the retention time with the accurate m/z and the retention time of standard solutions for the specific metabolite. The metabolites were quantified using standard calibration curves and were then normalized over the total ion counts present in each extract. As the bacillithiol standard is not commercially available, the identification of this molecule (the reduced form; monomer) was based on m/z only. We could not detect the oxidized form (dimer).
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available from the corresponding author on request.
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